MedPath

Cleansing Efficacy of Cosmetic Product

Not Applicable
Not yet recruiting
Conditions
Healthy Skin
Registration Number
NCT06956625
Lead Sponsor
Amazentis SA
Brief Summary

The aim of this study is to investigate the cleansing effect of one cosmetic product containing Mitopure against a particular matter model pollutant in comparison to an untreated control.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Written informed consent to participate in the study
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female and/or male
  • From 18 to 70 years of age
  • Healthy skin in the test area
  • Skin type on Fitzpatrick scale: I, II or III
Exclusion Criteria
  • Female subjects: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
  • Active skin disease at the test area
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
  • Any topical medication at the test area within the last 4 weeks prior to the start of the study and during the study
  • Documented allergies to cosmetic products and/or ingredients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Luminosity (L)Before pollutant application (t0), immediately after evaporation of the applied pollutant (t1), and 20 minutes after product rinse-off (t2)

Luminosity in test area assessed by HiRIS (High Resolution Imaging System) image analysis will be used to quantify cleaning efficacy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SGS proderm GmbH

🇩🇪

Schenefeld, Germany

© Copyright 2025. All Rights Reserved by MedPath